Chlorambucil

In some countries, this medicine may only be approved for veterinary use.

In the US, Chlorambucil (chlorambucil systemic) is a member of the drug class alkylating agents and is used to treat Cancer, Chronic Lymphocytic Leukemia, Hodgkin's Lymphoma and Lymphoma.

US matches:

• Chlorambucil

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01AA02

CAS registry number (Chemical Abstracts Service)

0000305-03-3

Chemical Formula

C14-H19-Cl2-N-O2

Molecular Weight

304

Therapeutic Category

Antineoplastic agent, alkylating agent

Chemical Name

Benzenebutanoic acid, 4-[bis(2-chloroethyl)amino]-

Foreign Names

• Chlorambucilum (Latin)
• Chlorambucil (German)
• Chlorambucil (French)
• Clorambucilo (Spanish)

Generic Names

• Chlorambucil (OS: BAN, DCF)
• Clorambucil (OS: DCIT)
• CB 1348 (IS)
• Chlorbutin (IS)
• CLB (IS)
• Chlorambucil (PH: BP 2010, Ph. Int. 4, USP 32, Ph. Eur. 6)
• Chlorambucilum (PH: Ph. Int. 4, Ph. Eur. 6)

Brand Names

• Chloraminophène
  Techni-Pharma, Monaco



• Leukeran
  Dr. Fisher, Netherlands; Euro, Netherlands; Glaxo Wellcome, Portugal; GlaxoSmithKline, United Arab Emirates; GlaxoSmithKline, Argentina; GlaxoSmithKline, Austria; GlaxoSmithKline, Australia; GlaxoSmithKline, Bangladesh; GlaxoSmithKline, Belgium; GlaxoSmithKline, Bahrain; GlaxoSmithKline, Brazil; GlaxoSmithKline, Canada; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Chile; GlaxoSmithKline, China; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Germany; GlaxoSmithKline, Denmark; GlaxoSmithKline, Estonia; GlaxoSmithKline, Egypt; GlaxoSmithKline, Ethiopia; GlaxoSmithKline, Finland; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Guyana; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Israel; GlaxoSmithKline, India; GlaxoSmithKline, Iraq; GlaxoSmithKline, Iran; GlaxoSmithKline, Iceland; GlaxoSmithKline, Italy; GlaxoSmithKline, Jordan; GlaxoSmithKline, Kuwait; GlaxoSmithKline, Lebanon; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Luxembourg; GlaxoSmithKline, Latvia; GlaxoSmithKline, Malta; GlaxoSmithKline, Mexico; GlaxoSmithKline, Netherlands; GlaxoSmithKline, Norway; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Oman; GlaxoSmithKline, Philippines; GlaxoSmithKline, Poland; GlaxoSmithKline, Qatar; GlaxoSmithKline, Romania; GlaxoSmithKline, Russian Federation; GlaxoSmithKline, Saudi Arabia; GlaxoSmithKline, Sweden; GlaxoSmithKline, Singapore; GlaxoSmithKline, Slovenia; GlaxoSmithKline, Slovakia; GlaxoSmithKline, Syria; GlaxoSmithKline, Thailand; GlaxoSmithKline, Turkey; GlaxoSmithKline, Taiwan; GlaxoSmithKline, United States; GlaxoSmithKline, Yemen; GlaxoSmithKline, South Africa; Heumann, Bulgaria; IFET, Greece; Wellcome, Spain; Wellcome, Ireland



• Leukeran (veterinary use)
  GlaxoSmithKline, United Kingdom

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.